Palliative Care in Parkinson Disease—Is It Beneficial for All?

Daniel G. Di Luca(University of Miami), Jason Margolesky(University of Miami), Carlos Singer(University of Miami Health System)

JAMA Neurology

September 8, 2020

10.1001/jamaneurol.2020.3212

Cited by 4

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

|JAMA|2016|397

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

|Sleep Medicine|2013|391

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

|Sleep Medicine|2013|238

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

|Neurology|2016|137

Genotype–Phenotype Relations in Primary Familial Brain Calcification: Systematic <scp>MDSGene</scp> Review

|Movement Disorders|2021|93